Smart inhalers market accounted forever US $137.6millionin 2019. The market is anticipated to grow at a CAGR of 11.5% from 2020 to 2030.
The market growth of smart inhalers can be attributed to factors such as the growing geriatric population globally and the rising number of patients suffering from respiratory diseases. According to the Office of Disease Prevention and Health Promotion, more than 25 million in the U.S. are suffering from asthma and 14.8 million adults have been diagnosed with COPD. Also, according to the WHO, smoking is considered to be a primary cause for COPD and more than 1 billion people inhale polluted air exposed to tobacco outdoors. These are among the primary factors that will lead to market growth.
Major Key Players of the Smart Inhalers Market are:
Astra Zeneca plc, GlaxoSmithKline plc, Novartis AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., AptarGroup, Inc., Vectura Group plc, Findair Sp. z o. o., H&T Presspart Manufacturing Ltd., and Zeolr Technologies Pvt Ltd, among others.
No comments:
Post a Comment